Watch: Probiotics and diabetes — 'A fantastically exciting' area for research

This content item was originally published on, a William Reed online publication.

By Gary Scattergood

- Last updated on GMT

Related tags Probiotic

Diabetes and other metabolic disorders are providing fertile ground for new probiotic research, says a DuPont expert who has highlighted new findings on supplementation and a reduced risk of gestational diabetes.

Speaking our Probiota Asia summit in Singapore last month, Dr Anders Henriksson discussed the increasing volume of literature that suggests probiotics have benefits far beyond the traditional realm of gastrointestinal health.

In our video, we assess some of the findings around diabetes and look at the potential for further research into metabolic disorders.

One of the latest studies Dr Henriksson addressed was a New Zealand RCT​ which sought to discover if supplementation with the probiotic Lactobacillus rhamnosus​ HN001 could reduce the prevalence of gestational diabetes mellitus.

It found that the prevalence of gestational diabetes was significantly lower in the HN001 group, and concluded that HN001 supplementation from 14 to 16 weeks' gestation may reduce the risk, particularly among older women.

Watch the video to find out more.

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Related suppliers

Follow us


View more